New research highlights a significant link between metabolic dysfunction-associated steatotic liver disease (MASLD), formerly ...

Often symptomless, fatty liver disease is becoming a leading cause of liver cancer. Learn the role of daily habits, early ...

The U.S. Food and Drug Administration approved the obesity drug Wegovy for people with the chronic liver disease known as ...

A new analysis from the Chile BiLS study evaluated the reliability of ultrasound imaging for diagnosing SLD in a high-risk ...

MASLD is among the most common types of chronic liver disease and is estimated to affect 30% of the global population.

South Korea: A large population-based study from South Korea has revealed a significant association between cholecystectomy ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a leading cause of hepatic fibrosis, yet its prevalence in asymptomatic ...

Fatty liver disease, now termed MASLD, often presents subtle abdominal symptoms like bloating and discomfort, even before ...

Echosens, the leader in non-invasive liver diagnostics, and Novo Nordisk are strengthening their aligned efforts to combat steatotic liver disease, following the U.S. Food and Drug Administration's ...

Dr Kolawole Akande, a consultant gastroenterologist at the University College Hospital (UCH) in Ibadan, in this interview with SADE OGUNTOLA, explains excessive fat in the liver as a dangerous ...

Discover a study exploring whether faecal microbiota transplantation can reduce liver fat and improve metabolic health in ...